Concepedia

Katherine Wesseling‐Perry

KW

39

Publications

2.6K

Citations

26

H-Index

2008

Active since

Affiliations

University of California, Los Angeles(Current)

Harvard University

Massachusetts General Hospital

UCLA Health

Karolinska Institutet

Katherine Wesseling‐Perry is an author at University of California, Los Angeles specializing in medicine, chronic kidney disease, and nephrology.

ORCID

Top concepts

Publications per year

2008–2021

39

Publications

39

Suppression of Iron-Regulatory Hepcidin by Vitamin D

Justine Bacchetta, Joshua J. Zaritsky, Jessica L Sea et al. · Journal of the American Society of Nephrology · 2013 · 339 citations · Full text

, , +17

Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease

Renata C. Pereira, Harald Jüppner, Carlos E. Azucena-Serrano et al. · Bone · 2009 · 264 citations · Full text

, , +10

Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

Takashi Shimada, Itaru Urakawa, Tamara Isakova et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 228 citations · Full text

Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes

Justine Bacchetta, Jessica L Sea, Rene F. Chun et al. · Journal of Bone and Mineral Research · 2012 · 188 citations · Full text

Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism

Katherine Wesseling‐Perry, Renata C. Pereira, Shobha Sahney et al. · Kidney International · 2010 · 165 citations · Full text

, , +8

Rows per page

1–5 of 39